Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Non-Current Deffered Revenue (2018 - 2025)

Historic Non-Current Deffered Revenue for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $385000.0.

  • Health Catalyst's Non-Current Deffered Revenue rose 4922.48% to $385000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $385000.0, marking a year-over-year increase of 4922.48%. This contributed to the annual value of $249000.0 for FY2024, which is 22337.66% up from last year.
  • Per Health Catalyst's latest filing, its Non-Current Deffered Revenue stood at $385000.0 for Q3 2025, which was up 4922.48% from $329000.0 recorded in Q2 2025.
  • Health Catalyst's 5-year Non-Current Deffered Revenue high stood at $1.1 million for Q1 2021, and its period low was $51000.0 during Q2 2024.
  • For the 5-year period, Health Catalyst's Non-Current Deffered Revenue averaged around $427631.6, with its median value being $315000.0 (2022).
  • In the last 5 years, Health Catalyst's Non-Current Deffered Revenue tumbled by 8869.75% in 2022 and then skyrocketed by 54509.8% in 2025.
  • Quarter analysis of 5 years shows Health Catalyst's Non-Current Deffered Revenue stood at $929000.0 in 2021, then tumbled by 88.7% to $105000.0 in 2022, then decreased by 26.67% to $77000.0 in 2023, then skyrocketed by 223.38% to $249000.0 in 2024, then skyrocketed by 54.62% to $385000.0 in 2025.
  • Its Non-Current Deffered Revenue was $385000.0 in Q3 2025, compared to $329000.0 in Q2 2025 and $407000.0 in Q1 2025.